ESG

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

A new 7,500-participant study will test a cfDNA-based screen to identify high-risk pregnancies months before symptoms appear, a potential paradigm shift.

Mawson Infrastructure reports a steep Q4 revenue drop but a smaller annual loss, clearing major legal hurdles to focus on its AI and green energy future.

HYXI makes its Nigerian debut with a fresh brand and robust energy solutions, signaling a major push into West Africa's booming renewable market.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

A new cancer drug using DNA fragments to deliver chemotherapy more safely has been cleared for US trials, offering hope for less toxic treatments.

With a new industrial leader, Lithium de France is accelerating its ambitious plan to supply one-third of the nation's lithium from geothermal sources.

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

A $41.25M deal for a new cottage-style community in Monroe, NC, highlights a growing housing trend and an investor's bet on 'affordable' suburban living.

Investors brace for South Bow's year-end results, seeking answers on pipeline repairs, new project cash flows, and its strategy in a shifting energy market.

Amid financial headwinds, specialty chemicals firm Orion S.A. will pitch its strategic pivot to the high-growth EV and sustainable materials markets.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

Viking Therapeutics' upcoming earnings call is about more than just financials. Investors are focused on key pipeline updates for its obesity and MASH drugs.

Stablecoin giant Tether's $150M investment in Gold.com signals a new era, merging physical gold with blockchain to redefine asset ownership.

GameAbove's new invitational isn't just another tournament; it's a strategic play to elevate women's golf, backed by millions in investment.

With the appointment of Kash Mohammed as President, intelliSPEC signals a major push to unify its platform and lead the AI revolution in industrial asset management.

A new TELUS and L-SPARK partnership gives startups access to a sovereign AI supercomputer, aiming to close Canada's compute gap and fuel national innovation.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.